Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Jersey for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Jersey only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Jersey (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Steven Bromley (NPI 1962591586)

Field	Value
Entity Type	Individual
Organization	Steven Bromley
Address	739 S. White Horse Pike
City	Audubon
State	NJ
ZIP	08106
Taxonomy	Neurology Physician
NPI Enumerated	October 12, 2006

Payer Source	Total Paid
Medicare	$2.9M
Medicaid	$0

Key Findings

This provider reports $2.9M in lifetime Medicare revenue and has no Medicaid billing on file, making their public billing footprint effectively single-payer (Medicare) in scope. The absence of Medicaid activity means analysts should treat competitive and payer-mix conclusions as Medicare-centric rather than balanced across state payers.

Revenue is highly concentrated in three biologic/injectable codes: J2350 accounts for 55.8% of Medicare revenue, J1459 for 22.7%, and J3032 for 11.6%, and the precomputed top-3 share is 90.1% of total Medicare revenue. That concentration indicates the practice’s financial performance is dominated by a small set of high-cost specialty drugs rather than broad office-based E/M billing.

The code mix (J2350 – ocrelizumab, J1459 – IVIG/Privigen, and J3032 – eptinezumab) points to a specialty neurology infusion operation that administers high-cost biologics and immune globulin products. High counts of infusion administration codes such as 96365 (712 claims, $54 avg paid/claim, ranks #186 nationally, 98th percentile) and 96366 (1.3K claims, $17 avg paid/claim, ranks #40 nationally, 99th percentile, labeled an extreme outlier) support an on-site infusion suite or dedicated infusion throughput.

On competitive standing for these specialty therapies the provider is a national high-volume participant: J3032 ranks #2 of 71 providers nationally (99th percentile) and is described as notably above typical national volume, J1459 ranks #3 of 44 providers (95th percentile) and J2350 ranks #8 of 105 providers (93th percentile). These ranks indicate the provider is a leading administrator of specific migraine and immunologic biologics relative to peers, rather than a low-volume or local-only operator for those products.

Several codes are statistical outliers in administration volume and suggest unusually high infusion activity: 96366 is called an "extreme outlier, far above typical national volume" (99th percentile), and J2930 (methylprednisolone) likewise appears as an "extreme outlier" with a 99th percentile rank (#33 of 2459). Such outlier labels signal unusually heavy use of additional infusion hours and certain injectable therapies compared with national peers.

Evaluation-and-management (E/M) services are present but represent a small share of revenue: 99215 (290 claims, $137 avg paid/claim, $39.7K revenue) is 1.4% of Medicare revenue and ranks #6211 of 145531 providers nationally (96th percentile, described as notably above typical), while 99214 (349 claims, $97 avg paid/claim, $33.9K revenue) is 1.2% of revenue and sits at the 83th percentile. This pattern suggests clinician E/M visits are part of the workflow but are not the primary revenue driver compared with infused biologics and IV therapies.

Lower-revenue supportive and infusion-supply codes are also billed (for example, J7050 saline 525 claims, $1 avg paid/claim, $525 revenue; and J1200 diphenhydramine 80 claims, $1 avg paid/claim), and there are modest chemotherapy-related charges (96413 and 96415) at small revenue levels. These items indicate the practice bills for routine infusion supplies and occasional additional infusion or chemotherapy services, albeit at much lower dollar impact than the top biologics.

The provider’s NPI was enumerated on 2006-10-12 (~20 years ago), indicating long tenure in the Medicare program. Combined with the concentrated specialty-drug billing and high administration-volume ranks, the longevity supports the view that this is an established infusion-focused neurology practice with a mature service line built around biologic injections and IVIG administration.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

21 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2350	Injection, ocrelizumab, 1 mg	34,500	$50	$1.6M
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	17,860	$40	$660.6K
J3032	Injection, eptinezumab-jjmr, 1 mg	25,900	$10	$336.7K
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	2,680	$40	$99.2K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	290	$140	$39.7K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	710	$50	$38.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	350	$100	$33.9K
96366	The provider administers an intravenous infusion or infusions of a medication for an additional hour or subsequent hours after the first hour to prevent, treat, or diagnose a condition or disease.	1,260	$20	$21.5K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	110	$170	$19.3K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	170	$110	$17.6K

Showing 1–10 of 21

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 21 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Jersey Distribution

Steven Bromley — 6 of 19 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Jersey

Full comparison — all codes billed, vs. state median

21 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2350	1	10	18,600	$50	$995.3K
J1459	1	10	17,860	$40	$665.8K
J3032	1	10	18,150	$10	$244.5K
J1561	2	10	2,680	$40	$100.3K
96413	123	230	190	$110	$26.6K
99214	3,224	13,640	130	$90	$23.6K
99213	7,908	14,090	100	$70	$13.1K
99215	219	3,750	40	$140	$12K
96365	10	320	90	$60	$8.5K
99204	6,610	7,160	40	$130	$6.5K

Showing 1–10 of 21

Related Providers

Other providers that share a Tax Identification Number (TIN) with Steven Bromley, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Virtua Medical Group, PA	NJ	Family Medicine Physician	$0	$48M
Somc Medical Care Foundation, Inc.	OH	Family Medicine Physician	$0	$25.3M
Summit Surgical Center LLC	NJ	Ambulatory Surgical Clinic/Center	$484.7K	$3.6M
Judith Lightfoot	NJ	Infectious Disease Physician	$647.5K	$0
Megdad Zaatreh	NJ	Neurology Physician	$582.2K	$3.8K
Jason Palermo	NJ	Cardiovascular Disease Physician	$536.8K	$0
Darius Sholevar	NJ	Clinical Cardiac Electrophysiology Physician	$482.5K	$0
Ralph Russo	NJ	Nuclear Cardiology Physician	$458K	$0
Heath Saltzman	NJ	Clinical Cardiac Electrophysiology Physician	$389.9K	$0
Aatish Garg	NJ	Clinical Cardiac Electrophysiology Physician	$381.4K	$0

Nearby Providers

Other providers in the same ZIP code as Steven Bromley, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Jeffrey Crawford	NJ	Cardiovascular Disease Physician	$203.5K	$0
Brad Rahaman	NJ	Emergency Medicine Physician	$145.6K	$14.8K
Melanie Hurst	NJ	Nurse Practitioner	$126.6K	$0

Steven Bromley — Billing Profile & Reimbursement Data

Sign up for Steven Bromley — Billing Profile & Reimbursement Data policy alerts

Steven Bromley — Billing Profile & Reimbursement Data

Sign up for Steven Bromley — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References